ISLAMABAD: Pakistan will soon start manufacturing anti-viral drug remdesivir to fight novel coronavirus under the license from a United States pharmaceutical company, said Special Assistant to the Prime Minister on National Health Services Dr Zafar Mirza.
Addressing a news briefing at the National Command and Operation Centre (NCOC) here today, the SAPM said that a national pharmaceutical company has reached an agreement with US-based Gilead for a voluntary license for the manufacture and sale of the anti-Covid-19 drug in Pakistan.
“The US-based company has allowed five countries to produce remdesivir to treat coronavirus patients. Pakistan is also among those to receive the license of the company,” he said, adding that the country will start production of the medicine as early as eight weeks after the necessary regulatory approvals are obtained.
The PM’s special aide further added that Pakistan will also be able to export the medicine to 127 countries.